Admission Date:  [**2171-8-2**]              Discharge Date:   [**2171-8-17**]  Date of Birth:  [**2086-10-27**]             Sex:   M  Service: MEDICINE  Allergies: Coumadin / Heparin Agents  Attending:[**First Name3 (LF) 3556**] Chief Complaint: L. hand hematoma   Major Surgical or Invasive Procedure: none  History of Present Illness: Mr [**Known lastname 9780**] is an 84 yo M with a history of cryptogenic cirrhosis (c/b variceal bleed requiring [**Last Name (un) 10045**]/TIPS [**2171-7-9**]) and afib/SSS (s/p dual chamber PPM) who was recently admitted from [**Date range (1) 108604**] with UGI bleed and who was admitted this time on [**2171-8-2**] with bilateral upper extremity ecchymosses that occurred in the setting of therapeutic enoxaparin.
Of note, the patient was recently admitted [**Date range (1) 108604**] with variceal bleeding, hypotension, and leukocytosis.
His dabigatran was stopped and he was discharged on lovenox.
Sick sinus syndrome with atrial fibrillation s/p Dual Chamber Pacemaker ([**Company 1543**] Revo MRI RVDR01).
Upper gastrointestinal bleed from AV malformations in the duodenum in [**2169**].
Prostate cancer [**2166**] status post radiation therapy.
Colon cancer [**2167**] status post colectomy incompletely, this is  now treated.
Status post inguinal hernia.
Portal Vein Thrombosis s/p thrombectomy [**2171-7-9**] 20.
He uses a cane to ambulate.
RUE noted to have hematoma over wrist with bandage in place and otherwise NVI.
no asterixis   Pertinent Results: [**2171-8-2**] 06:15PM BLOOD WBC-17.1*# RBC-2.31* Hgb-7.4* Hct-23.7* MCV-103* MCH-32.0 MCHC-31.1 RDW-20.4* Plt Ct-98* [**2171-8-3**] 06:45AM BLOOD WBC-20.4* RBC-1.94* Hgb-6.3* Hct-20.0* MCV-103* MCH-32.4* MCHC-31.5 RDW-20.7* Plt Ct-73* [**2171-8-2**] 06:15PM BLOOD Neuts-70 Bands-4 Lymphs-10* Monos-15* Eos-0 Baso-0 Atyps-0 Metas-1* Myelos-0 [**2171-8-2**] 06:15PM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-NORMAL Polychr-2+ Schisto-OCCASIONAL [**2171-8-2**] 06:15PM BLOOD PT-11.6 PTT-40.6* INR(PT)-1.1 [**2171-8-4**] 03:58AM BLOOD Fibrino-235 [**2171-8-2**] 06:15PM BLOOD Glucose-99 UreaN-24* Creat-1.0 Na-133 K-4.3 Cl-99 HCO3-25 AnGap-13 [**2171-8-3**] 06:45AM BLOOD ALT-44* AST-59* LD(LDH)-240 AlkPhos-130 TotBili-1.0 [**2171-8-4**] 04:00AM BLOOD CK-MB-5 cTropnT-0.01 [**2171-8-3**] 06:45AM BLOOD Calcium-8.3* Phos-3.4 Mg-2.2 [**2171-8-3**] 06:45AM BLOOD Hapto-15* [**2171-8-2**] 06:24PM BLOOD Lactate-2.1*  Micro: [**2171-8-17**] BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT [**2171-8-16**] URINE URINE CULTURE-NEG [**2171-8-13**] URINE URINE CULTURE-NEG [**2171-8-12**] STOOL C. difficile DNA amplification assay-NEG [**2171-8-12**] BLOOD CULTURE Blood Culture, Routine-NEG [**2171-8-12**] URINE URINE CULTURE- NEG [**2171-8-12**] BLOOD CULTURE Blood Culture, Routine- NEG [**2171-8-9**] URINE URINE CULTURE- NEG [**2171-8-8**] STOOL C. difficile DNA amplification assay-Neg [**2171-8-7**] STOOL C. difficile DNA amplification assay-Neg [**2171-8-7**] BLOOD CULTURE Blood Culture, Routine- NEG [**2171-8-6**] URINE Legionella Urinary Antigen - NEG [**2171-8-6**] URINE URINE CULTURE- VRE sensitive Linezolid  [**2171-8-6**] BLOOD CULTURE Blood Culture, Routine-NEG [**2171-8-6**] MRSA SCREEN MRSA SCREEN-NEG [**2171-8-4**] MRSA SCREEN MRSA SCREEN-NEG [**2171-8-4**] BLOOD CULTURE Blood Culture, Routine- NEG [**2171-8-4**] BLOOD CULTURE Blood Culture, Routine- NEG [**2171-8-3**] BLOOD CULTURE Blood Culture, Routine- NEG [**2171-8-3**] BLOOD CULTURE Blood Culture, Routine- NEG  STUDIES:  [**2171-8-2**] Chest Xray IMPRESSION:  No definite acute cardiopulmonary process.
He was transferred to the MICU on [**8-4**] for management of hypotension, hypoxia, and altered mental status  #) Septic Shock: Patient was found to be in septic shock with pulmonary source- CXR showed new left parenchymal opacity mid/lower lung zone.
A right subclavian was placed and fluid resuscitated by Rivers protocol.
Broad spectrum coverage with vanc, cefepime, and IV flagyl.
C diff assay was negative and Flagyl was DC'd.
Oral meds were convereted to IV, dilauded was DC'd, and C diff was found to be negative.
Patient started on Linezolid in context of increased WBC's on UA and urine Cx [**8-9**] growing VRE.
White count eventually trended down, but patient remained altered and NG tube placed.
The patient became hypothermic and required heating blanket.
The patient was restarted on vanc and cefepime after having completed an 8 day course.
O2 requirement remained between 2-5LNC.
Pressures improved with combination albumin and 500cc NS.
He was successfully rate controlled with a diltiazem drip and shortly after converted back to sinus rhythm.
His dilt gtt was stopped the morning after transfer to the ICU, but he continued to have Afib with RVR requiring digoxin and phenylephrine to support hypotension.
Nephrology determined this was ATN secondary to hypotension and given muddy brown casts, and the patient was given albumin.
In the ICU there was concern for compartment syndrome and ortho was consulted who cleared him for surgical concern.
The patient was noted to have a heparin sensitivity, and SQ heparin was stopped.
The patient was switched to pneumoboots for prophylaxis.
Continued on lactulose which was titrated to [**2-10**] BMs daily.
Received vit K to decrease INR towards a goal of 1.2.
Gentle fluid boluses with albumin were used to maintain pressures.
Medications on Admission: Preadmission medications listed are correct and complete.
Enoxaparin Sodium 90 mg SC BID 2.
Diltiazem 60 mg PO QID hold for SBP<100, HR<60 3.
Ferrous Sulfate 325 mg PO DAILY 4.
Furosemide 20 mg PO BID hold for SBP<100 5.
Lactulose 30 mL PO TID titrate to [**2-10**] BMs per day 6.
Levothyroxine Sodium 150 mcg PO DAILY 7.
Multivitamins 1 TAB PO DAILY 8.
Rifaximin 550 mg PO BID 9.
Pantoprazole 40 mg PO Q12H 10.
Atorvastatin 5 mg PO DAILY 11.
Fluticasone-Salmeterol Diskus (250/50)  1 INH IH DAILY   Discharge Disposition: Expired  Discharge Diagnosis: Respiratory Failure Acute renal failure   Discharge Condition: Expired                               [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 3559**] MD, [**MD Number(3) 3560**]
